Mona Frimann Larsen

Former labelling process manager at Novo Nordisk and founder of Vantage GMP&Labelling at Vantage GMP & Labelling

About me

Strategic Global Leader | Labelling Process & CAPEX Excellence High-impact professional with a 19-year track record at Novo Nordisk and Dako, specializing in end-to-end labeling strategy, large-scale packaging equipment, system infastructure and business value chain integration. Proven expertise in leading cross-functional teams to deliver multimillion-Danish-Krone (MDKK) automated production lines and pioneering digital transformations (ePI). A results-oriented process and project leader with a consistent history of zero-finding in regulatory and GMP inspections (e.g. Danish Medicines Agency) and a deep commitment to aligning short-term operational execution with long-term enterprise goals.

Schedule

Leveraging supply chain flexibility and limiting waste through labelling optimisation and regulatory strategy

Mona Frimann Larsen

Former labelling process manager at Novo Nordisk and founder of Vantage GMP&Labelling at Vantage GMP & Labelling

Wednesday - March 18, 2026 |
04:25 PM - 04:55 PM |
30 Minutes

Panel Discussion: Pharma Supply Chain Reinvented – From Fragile Networks to Intelligent Enterprises

Amid rising expectations and digital acceleration, pharma supply chains must evolve into intelligent, agile ecosystems. In this opening panel, senior leaders share how they’re reshaping operations, technology, and culture to build faster, smarter, and more sustainable networks.

How pharma leaders are reshaping processes and mindsets to embrace AI, digital twins, and predictive planning - not just tools, but transformation.
Strategies to embed responsiveness and flexibility into the core of supply chains, from network design to localized manufacturing and supplier collaboration.
Embedding sustainability into everyday decisions, from procurement to production and distribution.
Why tomorrow’s supply chain heads must be technologists, strategists, and culture builders, driving innovation amid constant disruption.